InsidersTradesSigma
Follow the 广生堂 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 广生堂 has logged 3 reports. Market capitalisation: €13.7bn. The latest transaction was filed on 17 March 2022 (Purchase). Among the most active insiders: 李国平. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
广生堂 is a company in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the development and production of medicines and health products.